PodParley PodParley

ANZUP 2017 Interviews - David Quinn

David Quinn discusses the KEYNOTE-045 trial on th…

An episode of the Talking Urology Podcast podcast, hosted by Talking Urology, titled "ANZUP 2017 Interviews - David Quinn" was published on November 29, 2017 and runs 16 minutes.

November 29, 2017 ·16m · Talking Urology Podcast

0:00 / 0:00

David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer

David Quinn discusses the KEYNOTE-045 trial on the benefits of pembrolizumab in second line treatment of advanced bladder cancer
URL copied to clipboard!